Sun Pharmaceutical Industries Share Price Today - Live Blog for July 28, 2025

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.31% in its share price, and it currently trades at ₹1,695.00 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.02% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,701.70 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.02%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,704.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd observed a -0.26% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,704.30. The stock has a PE ratio of 37.2900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.06%, reaching a current market price of ₹1,708.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.21% increase. Presently, it is actively trading at ₹1,709.00.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.08% surge in its share price and is presently trading at ₹1,704.70, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.09% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,703.35, making it an appealing option for investors.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.09% uptick, and they are currently valued at ₹1,703.35, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.01% decline, and it currently trades at ₹1,700.70 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a -0.04% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,699.75. The stock is currently trading at a PE of 37.2900, while the industry PE is 35.6163, prompting investors to assess its value proposition.

Sun Pharmaceutical Industries Ltd share price surged by 0.08%. With its current market price standing at ₹1,700.40 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd experienced a -0.05% dip in its share price and is currently trading at ₹1,700.10. The stock has a PE ratio of 37.2900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.05%, with the current market value at ₹1,700.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The share price of Sun Pharmaceutical Industries Ltd remained constant, with no changes. It is currently at ₹1,701.00. Investors may use this period of stability to conduct a thorough analysis of the stock's performance.

Sun Pharmaceutical Industries Ltd witnessed a -0.15% drop in its share price and is currently trading at ₹1,702.35. With the stock's PE at 37.2900 and the industry PE at 35.6163, investors are weighing their options.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.13%, and as of now, it's trading at ₹1,702.15 per share. This upward trajectory is attracting keen interest from investors.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.13% recently. As of now, this stock is actively trading at a current market price of ₹1,702.15 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd share price surged by 0.11%. With its current market price standing at ₹1,699.50 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.01%, and as of now, it's trading at ₹1,698.75 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.03%, reaching the current market price of ₹1,698.55. This surge is indicative of the stock's recent positive performance.

Sun Pharmaceutical Industries Ltd witnessed a -0.21% decrease in its share price, and it is currently trading at ₹1,697.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.2900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Demonstrating a commendable 0.17% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,700.00. In terms of valuation, the stock maintains a PE ratio of 37.2900, while the industry PE ratio stands at 35.6163.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.01% in its share price, and it currently trades at ₹1,698.35 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.16% in its share price, and it currently trades at ₹1,697.05 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.03% increase and currently trading at ₹1,698.55 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd witnessed a -0.75% decrease in its share price, and it is currently trading at ₹1,697.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.2900, an ROE of 15.1334% and a debt to equity ratio of 0.0327.